RxDoctor Payments Data

Jeffrey Neal, MD

Plastic Surgery within the Head & Neck · Abingdon, VANPI 1942384433

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by GSK at 30.5% of the total. Reporting peaked in 2021 at $330 and has fallen 53.1% since, to $155 in 2025.

$1,224in general payments, 2019–2025

Across 36 payments — averaging $34.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$373
  • Stryker$337
  • Regeneron Healthcare Solutions, Inc.$147
  • Pfizer$133
  • Benco Dental Supply Co.$74
  • AstraZeneca$49
  • plus $111 from 6 others

What the payments were for

  • Food & beverage$1,224100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$308,412
Medicare patients
860
Services billed
14,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth33$3,336
Fluticasone Propionate118$1,518
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$1,498
Famotidine193$1,358
Ipratropium Bromide46$1,125
Omeprazole149$976
Prednisone60$675
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav43$657
Clarithromycin15$434
Albuterol Sulfate HfaAlbuterol Sulfate12$363
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim35$294
Mometasone Furoate16$248
Nystatin16$196
Ciprofloxacin Hcl25$194
Fluconazole13$141

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Abingdon

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →